ReviewProstate cancer and prostatic diseases2021

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors.

Fred Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.